share_log

Mustang Bio Analyst Ratings

Benzinga ·  Aug 15, 2023 06:34
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
08/15/2023 520.35% HC Wainwright & Co. → $25 Reiterates Buy → Buy
06/16/2023 396.28% BTIG $4 → $20 Maintains Buy
06/16/2023 520.35% HC Wainwright & Co. → $25 Reiterates Buy → Buy
05/15/2023 73.7% HC Wainwright & Co. → $7 Reiterates Buy → Buy
03/30/2023 73.7% HC Wainwright & Co. → $7 Reiterates → Buy
11/16/2022 -0.74% BTIG $8 → $4 Maintains Buy
01/24/2022 48.88% B. Riley Securities $13 → $6 Maintains Buy
05/18/2021 172.95% BTIG → $11 Initiates Coverage On → Buy
12/23/2020 222.58% B. Riley FBR → $13 Reinstates → Buy
10/02/2020 123.33% B. Riley Securities → $9 Initiates Coverage On → Buy
05/12/2020 222.58% Oppenheimer $15 → $13 Maintains Outperform
11/20/2019 73.7% Cantor Fitzgerald → $7 Assumes → Overweight
08/13/2019 HC Wainwright & Co. Initiates Coverage On → Buy
08/13/2019 73.7% HC Wainwright & Co. → $7 Initiates Coverage On → Buy
06/21/2019 73.7% Cantor Fitzgerald → $7 Initiates Coverage On → Overweight

What is the target price for Mustang Bio (MBIO)?

The latest price target for Mustang Bio (NASDAQ: MBIO) was reported by HC Wainwright & Co. on August 15, 2023. The analyst firm set a price target for $25.00 expecting MBIO to rise to within 12 months (a possible 520.35% upside). 6 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Mustang Bio (MBIO)?

The latest analyst rating for Mustang Bio (NASDAQ: MBIO) was provided by HC Wainwright & Co., and Mustang Bio reiterated their buy rating.

When is the next analyst rating going to be posted or updated for Mustang Bio (MBIO)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Mustang Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Mustang Bio was filed on August 15, 2023 so you should expect the next rating to be made available sometime around August 15, 2024.

Is the Analyst Rating Mustang Bio (MBIO) correct?

While ratings are subjective and will change, the latest Mustang Bio (MBIO) rating was a reiterated with a price target of $0.00 to $25.00. The current price Mustang Bio (MBIO) is trading at is $4.03, which is within the analyst's predicted range.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment